Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $93.1278 (4.85%) ($88.7811 - $93.1278) on Fri. Nov. 30, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.96% (three month average) | RSI | 62 | Latest Price | $93.1278(4.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 2% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(51%) IVE(49%) SPLV(49%) IWD(48%) | Factors Impacting ABBV price | ABBV will decline at least -0.98% in a week (0% probabilities). TLT(-15%) DIA(-13%) VXX(-12%) VIXM(-12%) UUP(-11%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.98% (StdDev 1.96%) | Hourly BBV | 0 () | Intraday Trend | 4.4% | | | |
|
5 Day Moving Average | $88.32(5.44%) | 10 Day Moving Average | $87.76(6.12%) | 20 Day Moving Average | $86.73(7.38%) | To recent high | -1.6% | To recent low | 21.1% | Market Cap | $164.304b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |